Marc‐Antoine Valantin

3.6k citations

95 papers · 2.1k indexed · h-index 25

Virology top 0.5%
- HIV Research and Treatment 47
Hepatology top 1%
- Hepatitis C virus research 33
Infectious Diseases top 1%
- HIV/AIDS drug development and treatment 58
- HIV/AIDS Research and Interventions 30
Emergency Medicine top 1%
- HIV-related health complications and treatments 22
Dermatology top 2%
Epidemiology
- Hepatitis B Virus Studies 18
- Liver Disease Diagnosis and Treatment 10
Neurology
- CNS Lymphoma Diagnosis and Treatment 4

Co-authors: Christine Katlama Vincent Cálvez Anne‐Geneviève Marcelin Dominique Costagliola Roland Tubiana Marc Wirden Gilles Peytavin Jade Ghosn
Cited by: Virology Hepatology Infectious Diseases
Journals: PLoS ONE (6 papers)Hepatology (3 papers)Clinical Infectious Diseases (2 papers)
Partner nations: France United States Martinique

In The Last Decade

Marc‐Antoine Valantin

89 papers receiving 2.1k citations

Peers

Countries citing papers authored by Marc‐Antoine Valantin

Since Specialization

Citations

This map shows the geographic impact of Marc‐Antoine Valantin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc‐Antoine Valantin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc‐Antoine Valantin more than expected).

Fields of papers citing papers by Marc‐Antoine Valantin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc‐Antoine Valantin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc‐Antoine Valantin. The network helps show where Marc‐Antoine Valantin may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Marc‐Antoine Valantin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Marc‐Antoine Valantin Line = papers co-authored together Marc‐Antoine Valantin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Intermittent two-drug antiretroviral therapies maintain long-term viral suppression in real life in highly experienced HIV-infected patients Journal of Antimicrobial Chemotherapy ·Romain Palich,Basma Abdi,Marc Wirden,Panagiota Lourida,Roland Tubiana,Antoine Fayçal,Marc‐Antoine Valantin,Luminita Schneider,Sophie Seang,Rachid Agher,Anne Simon,Cathia Soulié,Minh Lê,Gilles Peytavin,Vincent Cálvez,Anne‐Geneviève Marcelin,Christine Katlama	2021	1
2	Kinetics of Archived M184V Mutation in Treatment-Experienced Virally Suppressed HIV-Infected Patients The Journal of Infectious Diseases ·Romain Palich,Elisa Teyssou,Sophie Sayon,Basma Abdi,Cathia Soulié,Lise Cuzin,Roland Tubiana,Marc‐Antoine Valantin,Luminita Schneider,Sophie Seang,Marc Wirden,Valérie Pourcher,Christine Katlama,Vincent Cálvez,Anne‐Geneviève Marcelin	2021	12
3	Low level of baseline resistance in recently HCV-infected men who have sex with men with high-risk behaviours Journal of Global Antimicrobial Resistance ·Thuy Ha Nguyen,Marc‐Antoine Valantin,Constance Delaugerre,Corinne Amiel,Emmanuelle Netzer,Thomas L’Yavanc,Michel Ohayon,Nadia Valin,Nesrine Day,Georges Kreplak,Gilles Pialoux,Vincent Cálvez,Jean‐Michel Molina,Anne‐Geneviève Marcelin,Ève Todesco	2021	0
4	Higher rates of HBsAg clearance with tenofovir-containing therapy in HBV/HIV co-infection PLoS ONE ·Pierre Gantner,Laurent Cotte,Clotilde Allavena,Firouzé Bani‐Sadr,Thomas Huleux,Claudine Duvivier,Marc‐Antoine Valantin,Christine Jacomet,Véronique Joly,Antoine Chéret,Pascal Puglièse,Pierre Delobel,André Cabié,David Rey,(unknown)	2019	18
5	INSTI-Based Triple Regimens in Treatment-Naïve HIV-Infected Patients Are Associated With HIV-RNA Viral Load Suppression at Ultralow Levels Open Forum Infectious Diseases ·Sidonie Lambert-Niclot,Anders Boyd,Djeneba Fofana,Nadia Valin,Marc Wirden,Jean‐Luc Meynard,Romain Palich,Rachid Agher,Marc‐Antoine Valantin,Vincent Cálvez,Christine Katlama,Pierre‐Marie Girard,Anne‐Geneviève Marcelin,Laurence Morand‐Joubert	2019	7
6	Ultrasensitive Human Immunodeficiency Virus Type 1 Viral Load as a Marker of Treatment Choice for Simplification Strategies Clinical Infectious Diseases ·Sidonie Lambert-Niclot,Maxime Grudé,Jean‐Luc Meynard,Anne‐Geneviève Marcelin,Marc‐Antoine Valantin,Philippe Flandre,Jacques Izopet,Laëtitia Moinot,Vincent Bouteloup,Vincent Cálvez,Christine Katlama,Pierre‐Marie Girard,Laurence Morand‐Joubert	2018	3
7	Derivation and internal validation of a mortality risk index for aged people living with HIV: The Dat'AIDS score PLoS ONE ·Maxime Hentzien,Cyrille Delpierre,Pascal Puglièse,Clotilde Allavena,Christine Jacomet,Marc‐Antoine Valantin,André Cabié,Lise Cuzin,David Rey,Firouzé Bani‐Sadr,Moustapha Dramé,(unknown)	2018	7
8	Incidence of new hepatitis C virus infection is still increasing in French MSM living with HIV AIDS ·Pierre Pradat,Thomas Huleux,F. Raffi,Pierre Delobel,Marc‐Antoine Valantin,Isabelle Poizot‐Martin,Pascal Puglièse,Jacques Reynes,David Rey,Bruno Hoën,André Cabié,Firouzé Bani‐Sadr,Antoine Chéret,Claudine Duvivier,Christine Jacomet,A. Frésard,Laurent Hustache‐Mathieu,Laurent Cotte	2018	38
9	Hepatitis C virus drives increased type I interferon-associated impairments associated with fibrosis severity in antiretroviral treatment-treated HIV-1–hepatitis C virus-coinfected individuals AIDS ·Morgane Griesbeck,Marc‐Antoine Valantin,Karine Lacombe,Assia Samri-Hassimi,Julie Bottero,Catherine Blanc,Zineb Sbihi,Rima Zoorob,Christine Katlama,Marguerite Guiguet,Marcus Altfeld,Brigitte Autran	2017	7
10	Lack of TGF-β production by hepatitis C virus-specific T cells during HCV acute phase is associated with HCV clearance in HIV coinfection Journal of Hepatology ·Sawsan Harfouch,Marguerite Guiguet,Marc‐Antoine Valantin,Assia Samri,Zineb Ouazene,Laurence Slama,Stéphanie Dominguez,Anne Simon,Ioannis Theodorou,Vincent Thibault,Brigitte Autran	2012	9
11	Prevalence of Low Bone Mineral Density in Men and Women Infected With Human Immunodeficiency Virus 1 and a Proposal for Screening Strategy Journal of Clinical Densitometry ·Murielle Mary‐Krause,Jean‐Paul Viard,Béatrice Ename-Mkoumazok,Michelle Bentata,Marc‐Antoine Valantin,Pascale Missy,Iuliana Darasteanu,Christian Roux,S. Kolta,Dominique Costagliola,Sylvie Rozenberg	2012	17
12	Historical HIV-RNA resistance test results are more informative than proviral DNA genotyping in cases of suppressed or residual viraemia Journal of Antimicrobial Chemotherapy ·Marc Wirden,Cathia Soulié,Marc‐Antoine Valantin,S. Fourati,Anne Simon,Sidonie Lambert-Niclot,Manuela Bonmarchand,C. Clavel-Osorio,Anne‐Geneviève Marcelin,Christine Katlama,Vincent Cálvez	2011	65
13	Influence of interferon-based therapy on liver fibrosis progression in HIV/HCV coinfected patients: A retrospective repeated liver biopsy analysis Journal of Hepatology ·Patrick Ingiliz,Marc‐Antoine Valantin,Paul Preziosi,Laetitia Finzi,R. Pais,Larysa Fedchuk,Stéphanie Dominguez,Christine Katlama,Thierry Poynard,Yves Benhamou	2011	13
14	Rosuvastatin versus pravastatin in dyslipidemic HIV-1-infected patients receiving protease inhibitors: a randomized trial AIDS ·E. Aslangul,Lambert Assoumou,Randa Bittar,Marc‐Antoine Valantin,Olga Kalmykova,Gilles Peytavin,Marie‐Hélène Fiévet,Franck Boccara,Dominique Bonnefont‐Rousselot,Jean‐Claude Melchior,Philippe Giral,Dominique Costagliola	2009	68
15	Liver damage underlying unexplained transaminase elevation in human immunodeficiency virus-1 mono-infected patients on antiretroviral therapy # Hepatology ·Patrick Ingiliz,Marc‐Antoine Valantin,Claudine Duvivier,Fadia Medja,Stéphanie Dominguez,Frédéric Charlotte,Roland Tubiana,Thierry Poynard,Christine Katlama,Anne Lombès,Yves Benhamou	2008	106
16	A case of acute renal failure associated with diffuse infiltrative lymphocytosis syndrome Nature Clinical Practice Nephrology ·Hassane Izzedine,Isabelle Brochériou,Marc‐Antoine Valantin,Laurent Camous,Edward Bourry,A Baumelou,Gilbert Deray,Christine Katlama	2008	7
17	Efficacy of early treatment of acute hepatitis C infection with pegylated interferon and ribavirin in HIV-infected patients AIDS ·Stéphanie Dominguez,Jade Ghosn,Marc‐Antoine Valantin,Aurélie Schruniger,Anne Simon,Philippe Bonnard,Éric Caumes,Gilles Pialoux,Yves Benhamou,Vincent Thibault,Christine Katlama	2006	85
18	Intérêt d'un nouveau test combiné antigène–anticorps pour le dépistage de l'infection par le virus de l'hépatite C : réduction de la fenêtre sérologique au cours de l'hépatite C aiguë chez le sujet co-infecté par le VIH Pathologie Biologie ·Aurélie Schnuriger,Stéphanie Dominguez,Marc‐Antoine Valantin,Roland Tubiana,Claudine Duvivier,Jade Ghosn,Anne Simon,Christine Katlama,Vincent Thibault	2006	2
19	Resistance mutations before and after tenofovir regimen failure in HIV-1 infected patients Journal of Medical Virology ·Marc Wirden,Anne‐Geneviève Marcelin,Anne Simon,Myriam Kirstetter,Roland Tubiana,Marc‐Antoine Valantin,Luc Paris,Manuela Bonmarchand,Françoise Conan,Laurence Kalkias,Christine Katlama,Vincent Cálvez	2005	16
20	MIV-310 reduces HIV viral load in patients failing multiple antiretroviral therapy AIDS ·Christine Katlama,Jade Ghosn,Roland Tubiana,Marc Wirden,Marc‐Antoine Valantin,Johan Harmenberg,Göran Mårdh,Bo Öberg,Vincent Cálvez	2004	15

About Marc‐Antoine Valantin

Marc‐Antoine Valantin is a scholar working on Virology, Hepatology and Infectious Diseases, having authored 95 papers that have together received 2.1k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (58 papers), HIV Research and Treatment (47 papers), Hepatitis C virus research (33 papers), HIV/AIDS Research and Interventions (30 papers), HIV-related health complications and treatments (22 papers), Hepatitis B Virus Studies (18 papers), Liver Disease Diagnosis and Treatment (10 papers) and CNS Lymphoma Diagnosis and Treatment (4 papers). The work is most often cited by research in Virology (1.1k citations), Hepatology (557 citations) and Infectious Diseases (1.3k citations). Marc‐Antoine Valantin has collaborated with scholars based in France, United States and Martinique. Frequent co-authors include Christine Katlama, Vincent Cálvez, Anne‐Geneviève Marcelin, Dominique Costagliola, Roland Tubiana, Marc Wirden, Gilles Peytavin, Jade Ghosn, Cathia Soulié and Claudine Duvivier. Their work appears in journals such as PLoS ONE, Hepatology and Clinical Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact